Key facts
- This page summarizes Mary Jo Janatpour's Form 3 filing for Aptevo Therapeutics Inc. (APVO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 May 2026, 20:03.
Mary Jo Janatpour - 20 May 2026 Form 3 Insider Report for Aptevo Therapeutics Inc. (APVO)
- Reporting relationship
- SVP, CSO
- Issuer ticker
- APVO
- Reported as of
- 20 May 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ SoYoung Kwon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Mary Jo Janatpour filed Form 3 for Aptevo Therapeutics Inc. (APVO) on 28 May 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002136251
Primary reporting owner
Janatpour Mary Jo
- Relationship
- SVP, CSO
- Address
- 2401 4TH AVENUE, SUITE 1050, SEATTLE
- Signature
- /s/ SoYoung Kwon, Attorney-in-Fact
- Signature date
- 28 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APVO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 20 May 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.